
Drugwatcher
Podkast av Paul
Drugwatcher (https://www.drugwatcher.org/) keeps the public up-to-date on litigation around defective medications and medical devices.
Prøv gratis i 7 dager
99,00 kr / Måned etter prøveperioden.Avslutt når som helst.
Alle episoder
8 Episoder
According to the Elmiron lawsuits recently filed in the US, this interstitial cystitis drug pentosan polysulfate sodium (PPS) is linked with serious eye damage. Plaintiffs claim the substance manufactured by Janssen Pharmaceuticals is linked with a certain type of retina damage known as pigmentary maculopathy that could lead to permanent vision loss [https://www.drugwatcher.org/elmiron-lawsuit/] and blindness. If you or a loved one developed any vision symptom associated with an eye disorder after taking Elmiron for interstitial cystitis or osteoarthritis, please call us now. First, we will do our best to ascertain whether your case qualifies to be brought to court, and if you may be entitled to compensation. Then, we will contact the best lawyer available to maximize your chances of winning. Support the show [https://www.drugwatcher.org/] (https://www.drugwatcher.org/)

In September 2019, the U.S. Food and Drug Administration (FDA) and drug-safety officials from the equivalent European agency issued a warning about Zantac and other ranitidine-based medications containing dangerous levels of N-nitrosodimethylamine (NDMA). This chemical is a dangerous and volatile substance that the U.S. Environmental Protection Agency (EPA) and the World Health Organization (WHO) classified as part of “a family of potent carcinogens” known as N-nitrosamines. Learn More: Zantac Lawsuit [https://www.drugwatcher.org/zantac-lawsuit/] Support the show [https://www.drugwatcher.org/] (https://www.drugwatcher.org/)

Hundreds of U.S. citizens who fell victim to the ongoing opioid epidemic filed a lawsuit to join the legal battle bravely fought by state attorneys and governmental agencies across the country. Every day more than 115 Americans meet their untimely fate after a drug overdose unjustly claims their lives. Too many unscrupulous pharmaceutical companies put their profit before public safety, and keep poisoning an entire country with potentially lethal narcotics. If you lost a family member to the side effects of opiate abuse and addiction, the time to seek a just compensation has come. File a litigation today, and take part of one of the largest civil actions in the American history. Learn More: Opioid Overdose Lawsuit [https://www.drugwatcher.org/opioids-lawsuit/] Support the show [https://www.drugwatcher.org/] (https://www.drugwatcher.org/)

IVC filters were designed to prevent blood clots from reaching vital organs. Some patients who received IVC filters claim that, among other things, the filters broke apart and migrated to other parts of the body where they caused sometimes life-threatening IVC filter complications. IVC Filter Lawsuits in 2020 [https://www.drugwatcher.org/ivc-filter-lawsuit/] As of January 2020, the total number of actions pending against C. R. Bard in the respective multidistric litigation (MDL) has reached a total of nearly 8,000 cases. The Cook IVC Filter MDL instead has surpassed 6,000 cases, although another approximately 1,000 have been settled or discarded already. Support the show [https://www.drugwatcher.org/] (https://www.drugwatcher.org/)

Essure is a minimally invasive form of female sterilization that was developed and brought to market by Conceptus, a subsidiary of Bayer AG. It has been legal in the U.S. since the FDA approved Essure in November 2002. Soon after Essure hit the market, women who had had the device implanted started to complain of pain and unintended pregnancies. To date, manufacturer Bayer has faced more than 17,000 lawsuits related to Essure [https://www.drugwatcher.org/essure-lawsuit/]. Support the show [https://www.drugwatcher.org/] (https://www.drugwatcher.org/)
Prøv gratis i 7 dager
99,00 kr / Måned etter prøveperioden.Avslutt når som helst.
Eksklusive podkaster
Uten reklame
Gratis podkaster
Lydbøker
20 timer i måneden